
Kevin S. Orwig
Examiner (ID: 15505, Phone: (571)270-5869 , Office: P/1611 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 3991, 1658, 1611 |
| Total Applications | 910 |
| Issued Applications | 256 |
| Pending Applications | 48 |
| Abandoned Applications | 609 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12238363
[patent_doc_number] => 20180071226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'Biocompatible Cross-Linked Micro-Nano Material Used for Drug Loading and Sustained Release and Construction Method Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/599710
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2338
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15599710
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/599710 | Biocompatible Cross-Linked Micro-Nano Material Used for Drug Loading and Sustained Release and Construction Method Thereof | May 18, 2017 | Abandoned |
Array
(
[id] => 14836187
[patent_doc_number] => 20190276494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES
[patent_app_type] => utility
[patent_app_number] => 16/302546
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32454
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302546 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES | May 18, 2017 | Abandoned |
Array
(
[id] => 18909321
[patent_doc_number] => 11872284
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Intrauterine device, and a method of reducing the rate of diffusion of active ingredients in said intrauterine device
[patent_app_type] => utility
[patent_app_number] => 15/600299
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 8668
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600299
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/600299 | Intrauterine device, and a method of reducing the rate of diffusion of active ingredients in said intrauterine device | May 18, 2017 | Issued |
Array
(
[id] => 12029637
[patent_doc_number] => 20170319736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'Compositions For Wound Treatment'
[patent_app_type] => utility
[patent_app_number] => 15/599399
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6648
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15599399
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/599399 | Compositions For Wound Treatment | May 17, 2017 | Abandoned |
Array
(
[id] => 13687619
[patent_doc_number] => 20170354764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => COATED BALLOON CATHETER AND COMPOSITION FOR COATING SAID BALLOON CATHETER
[patent_app_type] => utility
[patent_app_number] => 15/596231
[patent_app_country] => US
[patent_app_date] => 2017-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15596231
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/596231 | COATED BALLOON CATHETER AND COMPOSITION FOR COATING SAID BALLOON CATHETER | May 15, 2017 | Abandoned |
Array
(
[id] => 11942157
[patent_doc_number] => 20170246308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'Amino Acid Conjugates of Quetiapine, Process for Making and Using the Same'
[patent_app_type] => utility
[patent_app_number] => 15/595380
[patent_app_country] => US
[patent_app_date] => 2017-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15643
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15595380
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/595380 | Amino Acid Conjugates of Quetiapine, Process for Making and Using the Same | May 14, 2017 | Abandoned |
Array
(
[id] => 17405960
[patent_doc_number] => 11246819
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Compositions and methods for inhibiting biofilm deposition and production
[patent_app_type] => utility
[patent_app_number] => 16/301023
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 34
[patent_no_of_words] => 17623
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301023
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/301023 | Compositions and methods for inhibiting biofilm deposition and production | May 11, 2017 | Issued |
Array
(
[id] => 13714067
[patent_doc_number] => 20170367988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/589181
[patent_app_country] => US
[patent_app_date] => 2017-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15589181
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/589181 | Lipid nanoparticles comprising lipophilic anti-inflammatory agents and methods of use thereof | May 7, 2017 | Issued |
Array
(
[id] => 13519239
[patent_doc_number] => 20180311162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => SKIN BARRIER ENHANCING ARTICLE AND MANUFACTURING METHOD
[patent_app_type] => utility
[patent_app_number] => 15/583911
[patent_app_country] => US
[patent_app_date] => 2017-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15583911
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/583911 | SKIN BARRIER ENHANCING ARTICLE AND MANUFACTURING METHOD | Apr 30, 2017 | Abandoned |
Array
(
[id] => 11954813
[patent_doc_number] => 20170258964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'Porous Structures of Microbial-Derived Cellulose In Vivo Implantation'
[patent_app_type] => utility
[patent_app_number] => 15/487464
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 4322
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15487464
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/487464 | Porous Structures of Microbial-Derived Cellulose In Vivo Implantation | Apr 13, 2017 | Abandoned |
Array
(
[id] => 14210795
[patent_doc_number] => 20190117782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => CELLULARIZED HYDROGELS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/090114
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23545
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -68
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090114
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090114 | CELLULARIZED HYDROGELS AND METHODS OF USING THE SAME | Apr 3, 2017 | Abandoned |
Array
(
[id] => 15267429
[patent_doc_number] => 20190382448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => pH-SENSITIVE PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/087628
[patent_app_country] => US
[patent_app_date] => 2017-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087628
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/087628 | pH-sensitive cyclic peptides | Mar 20, 2017 | Issued |
Array
(
[id] => 11713471
[patent_doc_number] => 20170181971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'Nanoparticle- and Drug-Containing Polymersomes for Medical Applications'
[patent_app_type] => utility
[patent_app_number] => 15/455488
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9576
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15455488
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/455488 | Nanoparticle- and Drug-Containing Polymersomes for Medical Applications | Mar 9, 2017 | Abandoned |
Array
(
[id] => 17192175
[patent_doc_number] => 11160907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Medical device with a tubular portion comprising a thermoplastic elastomer with soft and hard segments, method for preparation thereof, and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/091040
[patent_app_country] => US
[patent_app_date] => 2017-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 7872
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091040
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091040 | Medical device with a tubular portion comprising a thermoplastic elastomer with soft and hard segments, method for preparation thereof, and use thereof | Mar 1, 2017 | Issued |
Array
(
[id] => 11942159
[patent_doc_number] => 20170246311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'PEPTIDES FOR BINDING ALTERNATIVELY ACTIVATED MACROPHAGES'
[patent_app_type] => utility
[patent_app_number] => 15/444301
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 18066
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15444301
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/444301 | PEPTIDES FOR BINDING ALTERNATIVELY ACTIVATED MACROPHAGES | Feb 26, 2017 | Abandoned |
Array
(
[id] => 11820648
[patent_doc_number] => 20170209586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'AMINO ACID CONJUGATES OF QUETIAPINE, PROCESS FOR MAKING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/431054
[patent_app_country] => US
[patent_app_date] => 2017-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15621
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15431054
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/431054 | AMINO ACID CONJUGATES OF QUETIAPINE, PROCESS FOR MAKING AND USING THE SAME | Feb 12, 2017 | Abandoned |
Array
(
[id] => 11662484
[patent_doc_number] => 20170151190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'AMANTADINE COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/430084
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 31612
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15430084
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/430084 | Method of administering amantadine prior to a sleep period | Feb 9, 2017 | Issued |
Array
(
[id] => 11662478
[patent_doc_number] => 20170151184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'AMANTADINE COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/428899
[patent_app_country] => US
[patent_app_date] => 2017-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 31619
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15428899
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/428899 | Method of administering amantadine prior to a sleep period | Feb 8, 2017 | Issued |
Array
(
[id] => 12143697
[patent_doc_number] => 09877933
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-30
[patent_title] => 'Method of administering amantadine prior to a sleep period'
[patent_app_type] => utility
[patent_app_number] => 15/428878
[patent_app_country] => US
[patent_app_date] => 2017-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 31613
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15428878
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/428878 | Method of administering amantadine prior to a sleep period | Feb 8, 2017 | Issued |
Array
(
[id] => 11662480
[patent_doc_number] => 20170151186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'AMANTADINE COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/428946
[patent_app_country] => US
[patent_app_date] => 2017-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 31621
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15428946
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/428946 | AMANTADINE COMPOSITIONS AND METHODS OF USE | Feb 8, 2017 | Abandoned |